Group 1 - Calumet, Inc. plans to attend the Bank of America Global Energy Conference in Houston on November 11, 2025, and will hold one-on-one investor meetings at the conference [1] - Calumet manufactures, formulates, and markets a diversified range of specialty branded products and renewable fuels for various consumer-facing and industrial markets [2] - The company is headquartered in Indianapolis, Indiana, and operates twelve facilities across North America [2] Group 2 - Montana Renewables, in collaboration with Calumet Montana Refining, has launched MaxSAF™ Blended, which advances sustainable aviation fuel by commissioning onsite blending and shipping facilities [4]

Core Insights - Lanxess AG reported an earnings per share (EPS) of -$0.01, missing the estimated EPS of $0.002 [1][5] - The company's actual revenue was approximately $1.54 billion, falling short of the estimated $1.64 billion [2][5] - Following the earnings report, Lanxess shares experienced a significant decline, dropping 14% [2][5] - The company adjusted its guidance to the lower end, with all business units underperforming expectations [2] Challenges - The underperformance is attributed to challenges such as Chinese dumping, US trade policies, weak demand, and uncertainty surrounding the sale of Envalior [2] - Despite these challenges, Lanxess has managed to maintain steady EBITDA margins, showcasing its resilience [3] Financial Ratios - The company has a price-to-earnings (P/E) ratio of approximately -8.88, indicating negative earnings [3] - The price-to-sales ratio stands at about 0.24, suggesting that the stock is valued at 24 cents for every dollar of sales [3] - The enterprise value to sales ratio is approximately 0.19, reflecting the company's valuation relative to its sales [3] - The enterprise value to operating cash flow ratio is around 2.59, indicating how many times the operating cash flow can cover the enterprise value [4] - The earnings yield is approximately -11.26%, consistent with the negative earnings situation [4] Liquidity Position - Lanxess maintains a strong liquidity position, with a current ratio of about 2.41, meaning its current assets are more than twice its current liabilities [4]

Financial Data and Key Metrics Changes - Sales for Q3 2025 were $485 million, down 12% from Q3 2024, reflecting ongoing market headwinds [5][13] - Adjusted EBITDA for Q3 2025 was $70.9 million, compared to $77.4 million in Q3 2024, with an adjusted EPS of $1.21 per share versus $1.37 last year [5][6] - SG&A expenses were down 14% on an adjusted basis compared to the prior year, equating to over $19 million in savings [6][8] Business Line Data and Key Metrics Changes - RPS sales decreased by $15 million (6%), PC sales were down $32 million (18%), and CM&C sales decreased by $21 million (16%) compared to the prior year [13] - RPS generated adjusted EBITDA of $29 million with a 12.5% margin, while PC delivered $26 million with an 18.1% margin, and CM&C reported $16 million with a 14.4% margin [13][14] Market Data and Key Metrics Changes - The utility and industrial products market saw a 6% increase in volumes year-over-year, while residential demand was down by about 5% [19][20] - The railroad products and services business experienced a 7% decline in treated ties sales units compared to the prior year [22] Company Strategy and Development Direction - The company is focusing on cost control and simplifying its business structure, including the sale of its railroad structures business and the closure of the ThioLignin hydride plant [8][9] - The Catalyst initiative aims to enhance operational efficiency and is expected to deliver approximately $80 million in ongoing benefits by the end of 2028 [28][29] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges faced in 2025 but expressed optimism for future growth, particularly in 2026 [32][33] - The company revised its consolidated sales guidance for 2025 to $1.9 billion, reflecting a soft demand environment across most markets [30][31] Other Important Information - The board declared a quarterly cash dividend of $0.08 per share, representing a 14% increase over the 2024 dividend [17] - The company ended Q3 2025 with a net leverage ratio of 3.4 times and $379 million in available liquidity [18] Q&A Session Summary Question: Concerns about cost management in the Performance Chemicals segment - Management indicated that costs are being managed, but they are cautious about cutting too deeply in PC due to its future potential [34][35] Question: Strategy for growing the utility pole business - The company sees significant market opportunities for growth in the utility pole sector and plans to expand its capabilities [38][39] Question: Outlook for the Performance Chemicals market - Management believes the current market setback is temporary and expects to see growth returning in line with historical trends [41][42]

Financial Data and Key Metrics Changes - The company delivered $200 million of operating cash in Q3 2025, with year-to-date free cash flow exceeding $100 million [7] - The latest dividend levels were adjusted down by 65%, resulting in approximately $60 million of cash requirements for the dividend next year, down from $115 million [9][49] - The company is on track to complete a $100 million cost reduction program, which includes the elimination or relocation of over 600 positions and the closure of seven sites, primarily in Europe [6][7] Business Line Data and Key Metrics Changes - The performance products division is expected to see modest recovery starting in 2026, with new capacities being introduced and improvements in contracts within automotive segments [56][57] - The maleic anhydride market remains strong in North America, with the company positioned as the low-cost producer [67] - Performance products volumes have been running down close to double digits, but the reduction is significantly influenced by the closure of the Moors site in Germany [66][68] Market Data and Key Metrics Changes - The U.S. economy is under pressure due to high inflation and rising interest rates, impacting consumer durables and home building [4][5] - Consumer confidence and spending in China are low, while European deindustrialization continues due to high business costs and regulations [5][6] - The U.S. MDI market is experiencing a sluggish demand, with a year-over-year growth of about 6% in Q3 2025 [36][72] Company Strategy and Development Direction - The company plans to continue calibrating its cost structure to align with market realities and manage cash flow during prolonged downturns [6][7] - There is a focus on sourcing energy-intensive raw materials from regions with more competitive costs, while maintaining a strong presence in profitable markets like aerospace and automotive [7][8] - The company is exploring opportunities for consolidations and rationalizing capacities to enhance competitiveness [8] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about a potential recovery in the U.S. and China economies as trade tensions ease and consumer confidence returns [5][6] - The company anticipates typical seasonality in Q4 2025, coupled with higher-than-average destocking, particularly in Europe [10] - Management emphasized the importance of protecting the balance sheet for long-term stability and growth [8][9] Other Important Information - The company is not planning to take on more debt to increase dividends and will consider dividend increases only when market conditions improve [9] - The company is actively managing working capital and has been aggressive in reducing inventory levels [13][15] Q&A Session Summary Question: Cash flow and inventory reduction actions in Q3 - Management indicated that inventory reduction actions may lead to lower utilization rates in Q4, but they aim to calibrate production to actual demand as they enter 2026 [13][17] Question: Risk of European manufacturing capacity leaving - Management is closely monitoring the situation and believes that their supply chain remains strong, particularly in Rotterdam, despite potential risks [22][24] Question: U.S. MDI imports from Europe - Management hopes that the increase in U.S. MDI imports from Europe is not a structural change, as it may not make economic sense in the long term [30][31] Question: Performance products market demand - Management expects gradual improvement in the maleic market and flat to positive performance in ethyleneamines, despite competitive conditions [66][67] Question: Future MDI growth rates - Management anticipates MDI growth to align with GDP growth, plus additional growth from product substitution, estimating a growth rate of about 1.5 times GDP [89]

Financial Data and Key Metrics Changes - The company reported a solid performance in Q3 2025, with expectations to grow EPS by $1 to $2 in 2026, even in a flat demand environment [6][7]. - Working capital has been a source of cash amounting to $250 million this year, with expectations for free cash flow in 2026 to be at least $700-$800 million [35][37]. Business Line Data and Key Metrics Changes - In the engineered materials segment, consolidated volumes were down 8% year-over-year, primarily affecting engineered thermoplastics like POM and nylon, while thermoplastic elastomers showed resilience [17][28]. - Pricing pressures were noted in the acetyl chain, particularly in Europe, while stabilization was observed in China [15][16]. Market Data and Key Metrics Changes - The company is experiencing a lower demand base compared to historical levels, with no significant accelerated destocking observed across the board, although some pockets exist [31][33]. - The U.S. assets are running at high rates, with the potential for increased utilization if demand improves [85]. Company Strategy and Development Direction - The company is focused on increasing cash flow, improving cost efficiencies, and driving top-line growth, particularly through its EM pipeline [6][7]. - A divestiture target of $1 billion by the end of 2027 has been set, with the recent Micromax transaction contributing significantly towards this goal [51][52]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving EPS growth despite a challenging demand environment, emphasizing the importance of cost actions and pipeline success [6][7]. - The company is actively evaluating its portfolio for potential divestitures, particularly in areas that do not align with its core business strategies [50][51]. Other Important Information - The company announced a closure of the Narco facility, expected to yield $20 million-$30 million in productivity savings by 2027 [40]. - An impairment related to Zytel and nylon was recorded due to a reduction in market cap, not cash flow projections [69][70]. Q&A Session Summary Question: Early look at 2026 earnings control - Management highlighted priorities for 2026, focusing on cash flow, cost improvements, and top-line growth, with an EPS growth expectation of $1 to $2 [6][7]. Question: Operating rates in the acetyl chain - The lowest-cost assets are running at full capacity, while other assets are flexibly operated based on demand [11][12]. Question: Sequential pricing pressure in the acetyl chain - Pricing pressure has been noted in Europe, with stabilization in China and relative stability in the U.S. [15][16]. Question: Volume decline in engineered materials - The decline is mainly in engineered thermoplastics, while thermoplastic elastomers have shown growth [17][28]. Question: Free cash flow expectations for 2026 - Free cash flow is expected to be at least $700-$800 million, with working capital actions contributing to this [35][37]. Question: Divestiture strategy and portfolio actions - The company is committed to divesting non-core assets, with a target of $1 billion by 2027, and is actively pursuing additional divestitures [50][51]. Question: Impact of European acetate tow closure - Management indicated that the closure would not have ripple effects across the acetates network [98].

Financial Performance - Q3 2025 - Revenues decreased to $1460 million from $1540 million in 3Q24[8], a decrease of approximately 5%[16] - Net loss attributable to Huntsman Corporation was $25 million, compared to a net loss of $33 million in 3Q24[8] - Adjusted net loss was $5 million, compared to an adjusted net income of $17 million in 3Q24[8] - Adjusted EBITDA decreased to $94 million from $131 million in 3Q24[8] - Free cash flow from continuing operations increased to $157 million from $93 million in 3Q24[8] Segment Performance - Q3 2025 - **Polyurethanes:** Revenues decreased to $956 million from $1003 million in 3Q24[11], and adjusted EBITDA margin was 5% compared to 8% in 3Q24[13] - **Performance Products:** Revenues decreased to $246 million from $280 million in 3Q24[20], a 12% decrease[25], and adjusted EBITDA margin was 12% compared to 15% in 3Q24[22] - **Advanced Materials:** Revenues increased slightly to $265 million from $261 million in 3Q24[28], a 2% increase[33], and adjusted EBITDA margin was 17% compared to 18% in 3Q24[30] Cash Flow and Liquidity - Cash flow from operations increased to $200 million in 3Q25 from $134 million in 3Q24[43] - Liquidity at the close of the quarter was $1372 million[43] - Net debt was $1540 million[43] Cost Realignment Plans - Targeted run rate benefits of approximately $100 million by the end of 2026[45] - Expected restructuring cash costs of approximately $80 million[45] - Total headcount reduction of approximately 500[45] Q4 2025 Outlook - Total adjusted EBITDA is expected to be between approximately $25 million and $50 million[52]

Q3 2025 Performance - Celanese reported Q3 2025 Free Cash Flow of $375 million[9] - Adjusted EPS for Q3 2025 was $1.34[9] - Adjusted EBIT for Engineered Materials was $200 million, and for Acetyl Chain was $187 million[9] Q4 2025 Outlook - Celanese anticipates an Adjusted EPS guidance of approximately $0.85 - $1.00 for Q4 2025[14] - The company projects Adjusted EBIT guidance for Engineered Materials to be between $165 million and $175 million, and for Acetyl Chain to be between $165 million and $180 million[15] Strategic Actions and Financial Health - Celanese is on track to achieve a Free Cash Flow target range of $700 million to $800 million for FY2025[27] - The company has a strong liquidity position, including $1.4 billion in cash and cash equivalents, along with a $1.75 billion undrawn revolving credit facility[33] - Celanese plans to use the net proceeds from the Micromax divestiture, valued at approximately $500 million, to pay down debt[22] - Celanese expects cost reduction actions to deliver $120 million in cost savings in 2025, with potential incremental opportunities of $50 million - $100 million[38]

Core Insights - Chemours reported $1.5 billion in revenue for Q3 2025, a year-over-year decline of 0.4% and an EPS of $0.20, down from $0.40 a year ago, indicating a significant drop in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $1.49 billion by 0.19%, while the EPS fell short of the consensus estimate of $0.24 by 16.67% [1] Revenue Performance - Other Segment revenues were $12 million, below the average estimate of $14.67 million, reflecting a year-over-year decline of 14.3% [4] - Titanium Technologies generated $612 million, compared to the average estimate of $634.1 million, marking a year-over-year decrease of 9.9% [4] - Advanced Performance Materials reported revenues of $311 million, exceeding the average estimate of $297 million, but still down 10.6% year-over-year [4] - Thermal & Specialized Solutions achieved $560 million in revenues, slightly below the average estimate of $563.96 million, but showing a year-over-year increase of 21.7% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Titanium Technologies was $25 million, significantly lower than the average estimate of $39.7 million [4] - Corporate and Other segment reported an adjusted EBITDA of -$38 million, better than the average estimate of -$50.99 million [4] - Other Segment adjusted EBITDA was $2 million, slightly below the average estimate of $2.31 million [4] - Advanced Performance Materials had an adjusted EBITDA of $14 million, close to the average estimate of $14.9 million [4] - Thermal & Specialized Solutions reported an adjusted EBITDA of $194 million, exceeding the average estimate of $179.85 million [4] Stock Performance - Chemours shares have declined by 19.9% over the past month, contrasting with a 1.3% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Core Insights - Celanese reported a revenue of $2.42 billion for the quarter ended September 2025, reflecting an 8.7% decline year-over-year and falling short of the Zacks Consensus Estimate of $2.46 billion, resulting in a surprise of -1.69% [1] - The company's EPS was $1.34, down from $2.44 in the same quarter last year, but exceeded the consensus estimate of $1.27 by 5.51% [1] Financial Performance Metrics - Net Sales for the Acetyl Chain segment were $1.06 billion, slightly below the estimated $1.07 billion, marking a 10.8% decrease compared to the previous year [4] - Net Sales from Inter segment eliminations were reported at -$26 million, worse than the estimated -$22.39 million, but showed a 13% improvement year-over-year [4] - Engineered Materials segment reported Net Sales of $1.38 billion, matching estimates but down 6.6% from the year-ago quarter [4] - Operating EBITDA for the Acetyl Chain was $250 million, below the average estimate of $258.55 million [4] - Operating EBITDA for Other Activities was -$48 million, slightly better than the estimated -$49.88 million [4] - Engineered Materials segment achieved an Operating EBITDA of $315 million, exceeding the average estimate of $285.07 million [4] Stock Performance - Celanese shares have declined by 13.4% over the past month, contrasting with a 1.3% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Huntsman Corporation reported third quarter 2025 results with revenues of $1,460 million, a decrease of 5% compared to $1,540 million in the same period of 2024 [2][10] - The net loss attributable to Huntsman was $25 million, an improvement from a net loss of $33 million in the prior year [2][10] - Adjusted EBITDA for the third quarter was $94 million, down from $131 million year-over-year [2][10] Financial Performance - Revenues for the nine months ended September 30, 2025, were $4,328 million, compared to $4,584 million in 2024, reflecting a 6% decline [13] - The diluted loss per share for Q3 2025 was $0.14, compared to a diluted loss per share of $0.19 in Q3 2024 [10] - Free cash flow from continuing operations increased to $157 million in Q3 2025 from $93 million in Q3 2024 [6][10] Segment Analysis - **Polyurethanes**: Revenues decreased by 5% to $956 million due to lower average selling prices, despite higher sales volumes [3][14] - **Performance Products**: Revenues fell by 12% to $246 million, primarily due to lower sales volumes and average selling prices [4][14] - **Advanced Materials**: Revenues increased by 2% to $265 million, driven by higher average selling prices [5][14] Cost Management and Restructuring - The company is on track with restructuring programs expected to yield over $100 million in savings by 2026 [2] - Operating expenses for Q3 2025 were $198 million, slightly higher than $192 million in Q3 2024 [13] Dividend and Capital Allocation - The Board of Huntsman Corporation decided to reset the regular dividend to $0.35 annually, a reduction of 65% from previous levels, to maintain financial flexibility [2][10] - The company anticipates returning to a higher dividend payout when conditions improve [2] Liquidity and Capital Resources - As of September 30, 2025, Huntsman had approximately $1.4 billion in combined cash and unused borrowing capacity [6] - Capital expenditures for Q3 2025 were $43 million, slightly up from $41 million in the same period of 2024 [7]